Literature DB >> 27864292

Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients.

Satoshi Nishiwaki1,2, Matsuyoshi Maeda3, Masahiro Yamada4, Shingo Okuno1, Yasuhiko Harada1, Kotaro Suzuki1, Shingo Kurahashi1, Fumihiro Urano4, Shozo Okamura4, Isamu Sugiura1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27864292     DOI： 10.1182/blood-2016-08-734947

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

Review 1.  The argument for using imatinib in CML.

Authors:  Simone Claudiani; Jane F Apperley
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia.

Authors:  David N Perdigoto; Sandra Lopes; Francisco Portela; Maria Augusta Cipriano; Luís Tomé
Journal:  GE Port J Gastroenterol       Date:  2017-10-28

3.  TKI-Related Platelet Dysfunction Does Not Correlate With Bleeding in Patients With Chronic Phase-Chronic Myeloid Leukemia With Complete Hematological Response.

Authors:  Yigit Sener; Mufide Okay; Seda Aydin; Yahya Buyukasik; Filiz Akbiyik; Zeliha Gunnur Dikmen
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

4.  Differential gene expression analysis of dasatinib-induced colitis in a patient with chronic myeloid leukemia followed for 3 years: a case report.

Authors:  Naoki Oshima; Yoshiyuki Mishima; Kotaro Shibagaki; Kousaku Kawashima; Norihisa Ishimura; Fumiyoshi Ikejiri; Chie Onishi; Takahiro Okada; Masaya Inoue; Ichiro Moriyama; Junji Suzumiya; Yoshikazu Kinoshita; Shunji Ishihara
Journal:  BMC Gastroenterol       Date:  2021-01-06       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.